Hangzhou Alltest Biotech Co. Ltd. A (688606) — Capital Reinvestment Ratio
Hangzhou Alltest Biotech Co. Ltd. A (688606) has a Capital Reinvestment Ratio of 0.69x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥55.21 Million) in capital expenditures (CN¥38.02 Million). Check Hangzhou Alltest Biotech Co. Ltd. A tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Hangzhou Alltest Biotech Co. Ltd. A Capital Reinvestment Ratio (2016–2025)
This chart tracks Hangzhou Alltest Biotech Co. Ltd. A's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see 688606 cash flow conversion.
Annual Capital Reinvestment Ratio for Hangzhou Alltest Biotech Co. Ltd. A (2016–2025)
Year-by-year Capital Reinvestment Ratio for Hangzhou Alltest Biotech Co. Ltd. A from 2016 to 2025. See 688606 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.06x | CN¥206.59 Million | CN¥219.10 Million | ▲ +58.4% |
| 2024 | 0.67x | CN¥329.52 Million | CN¥220.65 Million | ▼ -96.9% |
| 2023 | 21.54x | CN¥24.76 Million | CN¥533.49 Million | ▲ +10747.3% |
| 2022 | 0.20x | CN¥1.36 Billion | CN¥270.24 Million | ▲ +30.9% |
| 2021 | 0.15x | CN¥923.87 Million | CN¥140.12 Million | ▲ +154.5% |
| 2020 | 0.06x | CN¥622.72 Million | CN¥37.11 Million | ▼ -63.8% |
| 2019 | 0.16x | CN¥91.53 Million | CN¥15.09 Million | ▼ -91.2% |
| 2018 | 1.86x | CN¥18.60 Million | CN¥34.66 Million | ▼ -28.5% |
| 2017 | 2.61x | CN¥19.99 Million | CN¥52.12 Million | ▲ +740.1% |
| 2016 | 0.31x | CN¥6.72 Million | CN¥2.08 Million | — |